The Journal of Allergy and Clinical Immunology published a review conducted ...

The U.S. Food and Drug Administration approved topical ruxolitinib (Opzelura), the ...

Use patterns of topical calcineurin inhibitors (TCIs) were reviewed in 8,015 ...

The COVID-19 Research Database was used to assess the risk of ...

For patients with moderate-to-severe atopic dermatitis (AD), the FDA approved two ...

Do probiotic supplements improve the symptoms of atopic dermatitis (AD)? A ...

Warren R. Heymann, MD, FAAD offers his commentary on JAK inhibitors ...

One controversy over the last several decades is how hard water ...

The COVID-19 pandemic may impact patients with atopic dermatitis (AD) more. ...

A 7-year-old boy was evaluated for asymptomatic white spots of 2 ...